• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Quantifying lead-time bias in risk factor studies of cancer through simulation.通过模拟量化癌症风险因素研究中的领先时间偏倚。
Ann Epidemiol. 2013 Nov;23(11):735-41. doi: 10.1016/j.annepidem.2013.07.021. Epub 2013 Aug 27.
2
A mathematical model of case-ascertainment bias: Applied to case-control studies nested within a randomized screening trial.病例检出偏倚的数学模型:应用于嵌套在随机筛选试验中的病例对照研究。
PLoS One. 2018 Mar 19;13(3):e0194608. doi: 10.1371/journal.pone.0194608. eCollection 2018.
3
Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.前列腺特异性抗原筛查中的提前期和过度诊断:方法及背景的重要性
J Natl Cancer Inst. 2009 Mar 18;101(6):374-83. doi: 10.1093/jnci/djp001. Epub 2009 Mar 10.
4
Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies.随机试验和人群研究中癌症过度诊断有效实证估计的条件
Am J Epidemiol. 2016 Jul 15;184(2):140-7. doi: 10.1093/aje/kwv342. Epub 2016 Jun 29.
5
Prostate cancer incidence in light of the spatial distribution of another screening-detectable cancer.鉴于另一种可通过筛查检测出的癌症的空间分布情况的前列腺癌发病率。
Spat Spatiotemporal Epidemiol. 2013 Sep;6:1-6. doi: 10.1016/j.sste.2013.04.002. Epub 2013 Apr 25.
6
Association Between Alzheimer Disease and Cancer With Evaluation of Study Biases: A Systematic Review and Meta-analysis.阿尔茨海默病与癌症的关联及其研究偏倚评估:系统评价和荟萃分析。
JAMA Netw Open. 2020 Nov 2;3(11):e2025515. doi: 10.1001/jamanetworkopen.2020.25515.
7
Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.流行病学方法与应用概述:观察性研究设计的优势与局限性。
Crit Rev Food Sci Nutr. 2010;50 Suppl 1(s1):10-2. doi: 10.1080/10408398.2010.526838.
8
Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.新发转移性前列腺癌男性患者的发病率和 5 年死亡率趋势:基于 2 个全国队列的人群分析。
Cancer. 2018 Jul 15;124(14):2931-2938. doi: 10.1002/cncr.31384. Epub 2018 May 3.
9
Trade-Off between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era.前列腺癌筛查时代早期前列腺癌治疗与晚期前列腺癌发病风险的权衡。
J Urol. 2016 May;195(5):1397-1402. doi: 10.1016/j.juro.2015.11.056. Epub 2015 Dec 2.
10
Vasectomy and prostate cancer: a case-control study in India.输精管切除术与前列腺癌:印度的一项病例对照研究
Int J Epidemiol. 1997 Oct;26(5):933-8. doi: 10.1093/ije/26.5.933.

引用本文的文献

1
Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations.通过将疾病停留密度计算为偏微分方程来评估半马尔可夫过程和其他流行病学事件发生时间模型。
Med Decis Making. 2025 Jul;45(5):569-586. doi: 10.1177/0272989X251333398. Epub 2025 May 8.
2
Evidence-Based Periodic Health Examinations for Adults: A Practical Guide.《成人循证定期健康检查:实用指南》
Cureus. 2025 Mar 3;17(3):e79963. doi: 10.7759/cureus.79963. eCollection 2025 Mar.
3
Early prediction of mortality upon intensive care unit admission.重症监护病房入院时死亡率的早期预测。
BMC Med Inform Decis Mak. 2024 Dec 18;24(1):394. doi: 10.1186/s12911-024-02807-6.
4
SURVIVAL AND PROGNOSTIC FACTORS OF ANAL CANCER: A STUDY BASED ON DATA FROM THE HOSPITAL-BASED CANCER REGISTRY OF A HIGH-COMPLEXITY ONCOLOGY CARE CENTER.肛门癌的生存和预后因素:基于高复杂度肿瘤治疗中心医院癌症登记处数据的研究。
Arq Bras Cir Dig. 2024 Oct 28;37:e1830. doi: 10.1590/0102-6720202400037e1830. eCollection 2024.
5
An evidence-based approach to the routine use of optical coherence tomography.光学相干断层扫描常规应用的循证方法。
Clin Exp Optom. 2019 May;102(3):242-259. doi: 10.1111/cxo.12847. Epub 2018 Dec 17.
6
Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.经动脉化疗栓塞联合索拉非尼治疗不可切除肝细胞癌的系统评价与Meta分析
BMC Gastroenterol. 2018 Sep 4;18(1):138. doi: 10.1186/s12876-018-0849-0.
7
A mathematical model of case-ascertainment bias: Applied to case-control studies nested within a randomized screening trial.病例检出偏倚的数学模型:应用于嵌套在随机筛选试验中的病例对照研究。
PLoS One. 2018 Mar 19;13(3):e0194608. doi: 10.1371/journal.pone.0194608. eCollection 2018.

本文引用的文献

1
Prostate-cancer mortality at 11 years of follow-up.前列腺癌死亡率随访 11 年后。
N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135.
2
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.随机前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中的前列腺癌筛查:13 年随访后的死亡率结果。
J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.
3
Screening and prostate-cancer mortality in a randomized European study.一项欧洲随机研究中的筛查与前列腺癌死亡率
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
4
Mortality results from a randomized prostate-cancer screening trial.一项前列腺癌随机筛查试验的死亡率结果。
N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18.
5
Computational methods in medical decision making: to screen or not to screen?医学决策中的计算方法:筛查还是不筛查?
Stat Med. 2005 Feb 28;24(4):569-81. doi: 10.1002/sim.2037.
6
Test sensitivity of prostate-specific antigen in the Finnish randomised prostate cancer screening trial.芬兰前列腺癌随机筛查试验中前列腺特异性抗原的检测敏感性
Int J Cancer. 2004 Oct 10;111(6):940-3. doi: 10.1002/ijc.20352.
7
Invited commentary: screening as a nuisance variable in cancer epidemiology: methodological considerations.特邀评论:癌症流行病学中作为干扰变量的筛查:方法学考量
Am J Epidemiol. 2003 Jun 1;157(11):962-4. doi: 10.1093/aje/kwg063.
8
Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it.在癌症流行病学研究中对筛查史进行调整:为何、何时以及如何进行调整。
Am J Epidemiol. 2003 Jun 1;157(11):957-61. doi: 10.1093/aje/kwg062.
9
Prostate cancer in Italy before and during the 'PSA era': survival trend and prognostic determinants.意大利“前列腺特异性抗原(PSA)时代”前后的前列腺癌:生存趋势及预后决定因素
Eur J Cancer Prev. 2003 Apr;12(2):145-52. doi: 10.1097/00008469-200304000-00008.
10
Estimating causal effects.估计因果效应。
Int J Epidemiol. 2002 Apr;31(2):422-9.

通过模拟量化癌症风险因素研究中的领先时间偏倚。

Quantifying lead-time bias in risk factor studies of cancer through simulation.

机构信息

Department of Environmental Health Sciences, School of Public Health, University of Minnesota, Rochester, MN.

出版信息

Ann Epidemiol. 2013 Nov;23(11):735-41. doi: 10.1016/j.annepidem.2013.07.021. Epub 2013 Aug 27.

DOI:10.1016/j.annepidem.2013.07.021
PMID:23988688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3839248/
Abstract

PURPOSE

Lead-time is inherent in early detection and creates bias in observational studies of screening efficacy, but its potential to bias effect estimates in risk factor studies is not always recognized. We describe a form of this bias that conventional analyses cannot address and develop a model to quantify it.

METHODS

Surveillance Epidemiology and End Results (SEER) data form the basis for estimates of age-specific preclinical incidence, and log-normal distributions describe the preclinical duration distribution. Simulations assume a joint null hypothesis of no effect of either the risk factor or screening on the preclinical incidence of cancer, and then quantify the bias as the risk-factor odds ratio (OR) from this null study. This bias can be used as a factor to adjust observed OR in the actual study.

RESULTS

For this particular study design, as average preclinical duration increased, the bias in the total-physical activity OR monotonically increased from 1% to 22% above the null, but the smoking OR monotonically decreased from 1% above the null to 5% below the null.

CONCLUSIONS

The finding of nontrivial bias in fixed risk-factor effect estimates demonstrates the importance of quantitatively evaluating it in susceptible studies.

摘要

目的

在早期检测中存在领先时间,这会导致筛查效果的观察性研究产生偏倚,但人们并不总是认识到它对危险因素研究中效应估计的潜在偏倚。我们描述了一种常规分析无法解决的这种偏倚形式,并开发了一种量化它的模型。

方法

监测流行病学和结局研究(SEER)数据构成了特定年龄组临床前发病率的估计基础,对数正态分布描述了临床前持续时间分布。模拟假设风险因素或筛查对癌症临床前发病率没有影响的联合零假设,然后从这个零研究中量化风险因素比值比(OR)的偏倚。这种偏差可以作为调整实际研究中观察到的 OR 的因素。

结果

对于这种特殊的研究设计,随着平均临床前持续时间的增加,总体力活动 OR 的偏差从零假设的 1%单调增加到 22%,而吸烟 OR 则从零假设的 1%单调下降到 5%。

结论

在固定风险因素效应估计中发现实质性偏倚,证明了在易感研究中定量评估它的重要性。